Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06897878 · ClinicalTrials.gov registry record
Optimal Number of Pleural Biopsies During Pleuroscopy
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 104
- Enrollment target
NCT06897878: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06897878 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06897878 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
A single-center, non-randomized, prospective observational, pilot study designed to determine what is the optimal number of pleural biopsies to take during pleuroscopy.
Primary Outcome
The number of pleural biopsies needed to reach a diagnosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2024-12-05 |
| Est. Completion | 2025-12-18 |
What the finished NCT06897878 record still lists
NCT06897878 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06897878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06897878 about?
NCT06897878 is a clinical study titled "Optimal Number of Pleural Biopsies During Pleuroscopy". A single-center, non-randomized, prospective observational, pilot study designed to determine what is the optimal number of pleural biopsies to take during pleuroscopy.
What is the current status of trial NCT06897878?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2024-12-05. Estimated completion is 2025-12-18.
Who is sponsoring clinical trial NCT06897878?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI